Novo Nordisk, the maker of Ozempic and Wegovy, and Eli Lilly have both contended that compounded versions of their medications are unsafe
E&OE The author was formerly executive director of Indian Journal of Clinical Practice in an era when there were only JAMA and BMJ as the leading medical journals available for Indian clinicians
"Efficacy and safety of cagrilintide for weight management: A randomized phase 2 trial." Obesity , 31(3), 687-699
Effects of weight loss in overweight/obese individuals and longterm lipid outcomesa systematic review
This scientific uncertainty, compounded by the drugs unavailability in China, highlights an imperative to explore alternative therapeutic pathways independent of the leptin-melanocortin system
They were then reacted with corresponding Alexa Fluor 488- or 594-conjugated secondary IgG (Supplementary Table S1) at RT for 1 h